Prescription drug · ANDA
Saxagliptin NDC 0378-4706
Saxagliptin hydrochloride dihydrate 5 mg/1 · Tablet, Film coated · Oral · Mylan Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0378-4706-77 | 0037847067700378470677 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4706-77)Marketed from Aug 4, 2023 | |
| 0378-4706-93 | 0037847069300378470693 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4706-93)Marketed from Aug 4, 2023 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Saxagliptin
- Generic name (nonproprietary)
- saxagliptin
- Active ingredients
- Saxagliptin hydrochloride dihydrate — 5 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Mylan Pharmaceuticals Inc.NDC labeler code 0378
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205980
- Marketing start
- Listing expires
- Other FDA classes
- Dipeptidyl Peptidase 4 Inhibitors (Mechanism)
- Identifiers
- Product ID 0378-4706_5844f950-ed79-43de-a6c4-2233878a9222SPL ID 5844f950-ed79-43de-a6c4-2233878a9222SPL set ID 6e8d8c4f-96eb-4b64-9c8c-4a5448a23a78RxCUI 858036, 858042UNII 4N19ON48ZNUPC 0303784705933
- Pharmacologic class
- Dipeptidyl Peptidase 4 Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400378470677followed by a unit qualifier and the quantityPackage 00378-4706-77. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Saxagliptin tablets are a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1.1 ) Limitations of use: • Not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis. ( 1.2 ) 1.1 Monotherapy and Combination Therapy Saxagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [ see Clinical Studies (14) ]. 1.2 Limitations of Use Saxagliptin tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
Excerpt only. Read the full label for complete information.
About NDC 0378-4706
- What is NDC 0378-4706?
- 0378-4706 is the product NDC for Saxagliptin, Saxagliptin hydrochloride dihydrate 5 mg/1 tablet, film coated, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Saxagliptin.
- What is the active ingredient?
- Saxagliptin hydrochloride dihydrate.
- Who is the labeler?
- Mylan Pharmaceuticals Inc., NDC labeler code 0378. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Saxagliptin?
- 5 other product NDCs are listed under this name. See all Saxagliptin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Saxagliptin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Saxagliptin | Saxagliptin hydrochloride dihydrate 2.5 mg/1 | Tablet, Film coatedOral | Mylan Pharmaceuticals Inc. | 0378-4705 | 00378-4705-7700378-4705-93 |
| Saxagliptin | Saxagliptin hydrochloride 2.5 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 65862-825 | 65862-0825-0165862-0825-0565862-0825-30+1 more |
| Saxagliptin | Saxagliptin hydrochloride 5 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 65862-826 | 65862-0826-0165862-0826-0565862-0826-30+1 more |
| Saxagliptin | Saxagliptin hydrochloride 2.5 mg/1 | Tablet, Film coatedOral | Glenmark Pharmaceuticals Inc., USA | 68462-726 | 68462-0726-0568462-0726-3068462-0726-90 |
| Saxagliptin | Saxagliptin hydrochloride 5 mg/1 | Tablet, Film coatedOral | Glenmark Pharmaceuticals Inc., USA | 68462-727 | 68462-0727-0568462-0727-1468462-0727-30+1 more |
Other NDCs under ANDA 205980
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Saxagliptin | Saxagliptin hydrochloride dihydrate 2.5 mg/1 | Tablet, Film coatedOral | Mylan Pharmaceuticals Inc. | 0378-4705 |